Primary Operation with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-Year Follow-Up of Protocol MF07-01 Randomized Clinical Trial

The final analysis of the MF07-01 randomized study shows improvement in median overall survival during the 10-year follow-up period for patients who underwent primary breast operation for de novo stage IV breast cancer.

Source: Journal of the American College of Surgeons - September 13, 2021 Category: Surgery Authors: Atilla Soran, Vahit Ozmen, Serdar Ozbas, Hasan Karanlik, Mahmut Muslumanoglu, Abdullah Igci, Nuh Zafer Canturk, Zafer Utkan, Turkkan Evrensel, Efe Sezgin, MF07-01 Study Group Tags: Original Scientific Article Source Type: research